<DOC>
	<DOCNO>NCT02075658</DOCNO>
	<brief_summary>Renal cancer traditionally treat surgical removal tumor , tumor resistant chemotherapy radiation . The traditional treatment , entire kidney tumor remove abdominal incision , may long term problem actual cancer . As result , less invasive technique develop laparoscopic surgery abdomen inflate carbon dioxide ( i.e . via insufflation system ) surgery perform special instrument small port , know trocars . Rapid advance minimally invasive surgical technique demand ongoing technological improvement . Conventional insufflators trocars allow laparoscopic surgery occur , however system account pressure change within abdomen instrument insert remove . The AirSeal® System consist insufflation , filtration , recirculation system ( AirSeal® IFS ) , triple lumen filter tube set , valve free trocar ( AirSeal® Access Port ) design create maintain pressure barrier throughout procedure . The objective study collect comparative physiological , pulmonary compliance surgical utility data AirSeal® System conventional insufflators trocars control population undergo laparoscopic/robotic renal peri-renal procedure . Subjects enrol study procedure perform use either AirSeal® System conventional insufflator trocars . Both system clear use FDA 's 510 ( k ) process currently employ clinical practice , include University California , Irvine Medical Center . We hypothesize use AirSeal® System , laparoscopic efficiency outcomes significantly great conventional insufflator trocars system .</brief_summary>
	<brief_title>A Comparative Study Between AirSeal , Integrated Insufflation System , Conventional Insufflation</brief_title>
	<detailed_description>Rapid advance minimally invasive surgical technique demand ongoing technological improvement . The benefit laparoscopic surgery patient comfort recovery make procedure cholecystectomy gastric bypass . The AirSeal® System consist insufflation , filtration , recirculation system ( AirSeal® IFS ) , triple lumen filter tube set , valve free trocar ( AirSeal® Access Port ) . The device enable peritoneal access novel mechanism maintain pneumoperitoneum without mechanical seal . Specifically , AirSeal® System create pressure barrier within proximal housing cannula act invisible seal maintain pneumoperitoneum course surgery . It utilize re-circulation filtration control unit ( AirSeal® IFS ) design specifically AirSeal® Access Port create maintain pressure barrier . The AirSeal® System applications abdominal minimally invasive surgical procedure establish path entry laparoscopic instrument . The insufflation recirculation system ( AirSeal® IFS ) reusable AirSeal® Access Port triple lumen filter tube set design single patient use device . The 1st generation AirSeal® System receive FDA 510 ( k ) clearance 2007 current system receive FDA 510 ( k ) Clearance May 2011 . Since time , AirSeal™ system use routinely center throughout United States observe surgeon anesthesia team provide gentle , stable , consistent pneumoperitoneum . Initial evidence report literature1 . Kavoussi colleague state ; `` We find patient blunt end-tidal carbon dioxide ( CO2 ) level CO2 elimination rate compare CO2 elimination rate observe study evaluate transperitoneal laparoscopy use conventional trocar . To determine difference truly exist , CO2 elimination rate must prospectively analyze head head comparison valve-less conventional trocars . '' This study design compare physiological impact pulmonary compliance patient undergoing laparoscopic/robotic renal peri-renal surgery without AirSeal® System . 1 A new Valve-Less Trocar Urology Laparoscopy : Initial Evaluation . Journal Endourology 2009 ; 23 : 1535-39</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>1 . Competent adult ( 18 year age old ) male female . 2 . Persons undergo laparoscopic/robotic renal perirenal procedure . Exclusion criterion : 1 . Under age 18 2 . Unable provide inform consent 3 . Have history ascites 4 . History transplant kidney 5 . Solitary kidney ( one kidney ) 6 . Uncontrolled Diabetes ( HbA1c &gt; 8 ) 7 . Pregnancy ( noted standard care history physical ) 8 . Women breastfeed 9 . History narcotic abuse chronic pain 10 . Emergency Surgery 11 . Person 's participate research</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>renal cell carcinoma</keyword>
	<keyword>minimally invasive procedure</keyword>
	<keyword>robotic nephrectomy</keyword>
	<keyword>laparoscopic nephrectomy</keyword>
	<keyword>pneumoperitoneum</keyword>
	<keyword>trocars</keyword>
	<keyword>AirSeal® IFS</keyword>
</DOC>